BeOne Medicines
ONC
#900
Rank
A$38.92 B
Marketcap
A$375.22
Share price
1.62%
Change (1 day)
-11.80%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): A$7.13

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is A$6.82. In 2025 the company made an earnings per share (EPS) of A$3.87 an increase over its 2024 EPS that were of A-$8.85.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$7.1384.07%
2025A$3.87-143.75%
2024A-$8.85
2022A-$27.6628.21%
2021A-$21.58-19.96%
2020A-$26.9620.81%
2019A-$22.3231.52%
2018A-$16.97417.57%
2017A-$3.28-37.16%
2016A-$5.22158.95%
2015A-$2.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.34-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.35-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA